Repligen Expects Slower Growth In APAC, Builds Portfolio On Heels Of FlexBiosys Deal

Zinger Key Points
  • The company expects 2023 to be a challenging year due to a slower recovery in order growth in Asia Pacific.
  • Total reported revenue is expected to see a 5% downward adjustment to the previous guidance of $760-$800 million.

Repligen Corp RGEN reported Q1 FY23 sales of $182.66 million, down 12% Y/Y as reported, beating the consensus of $181.43 million

  • Adjusted EPS fell 30.4% to $0.64, beating the consensus of $0.59.
  • The company expanded its single-use fluid management offering by acquiring FlexBiosys Inc recently. "Strategically, we continue to build out our Fluid Management portfolio with the April acquisition of FlexBiosys, adding single-use bags to our suite of products," Chief Executive Officer J. Hunt said.
  • Adjusted gross profit in Q1 was $100.8 million, down 19% Y/Y. The adjusted gross margin contracted 520 basis points to 55.2%, compared to 60.4% a year ago.
  • Adjusted EBITDA in Q1 was $48.9 million, lower than $72.2 million a year ago.
  • The cash and equivalents were $618 million.
  • The company expects 2023 to be a challenging year due to a slower recovery in order growth in Asia Pacific, particularly in China.
  • FY23 Guidance: Repligen lowered its guidance for FY23.
  • Total reported revenue is expected to be in the range of $720-$760 million, a 5% downward adjustment to the previous guidance of $760-$800 million. The consensus estimate stands at $779.98 million.
  • The gross margin is expected to be 52%-53%, compared with previous guidance of 52.5%-53.5%.
  • The company forecasts adjusted EPS of $2.35-$2.42, lower than the previous guidance of $2.61-$2.69. The consensus stands at $2.64.

Price Action: RGEN shares are up 5.5% at $161.98 during the market session on the last check Tuesday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsEquitiesM&ANewsGuidanceTop StoriesMarketsGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!